23andMe Holding Co. (ME)
Largest Insider Buys in Sector
ME Stock Price History Chart
ME Stock Performance
About 23andMe Holding Co.
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
Insider Activity of 23andMe Holding Co.
Over the last 12 months, insiders at 23andMe Holding Co. have bought $0 and sold $176,335 worth of 23andMe Holding Co. stock.
On average, over the past 5 years, insiders at 23andMe Holding Co. have bought $1.83M and sold $339,482 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 11,467 shares for transaction amount of $50,558 was made by Lovell Evan () on 2022‑03‑10.
List of Insider Buy and Sell Transactions, 23andMe Holding Co.
| 2024-05-02 | Sale | Chief Administrative Officer | 38,551 0.0078% | $0.49 | $19,048 | -32.71% | ||
| 2024-04-18 | Sale | Chief Administrative Officer | 38,548 0.0074% | $0.47 | $18,148 | -32.25% | ||
| 2024-04-04 | Sale | Chief Administrative Officer | 38,548 0.0085% | $0.50 | $19,282 | -24.04% | ||
| 2024-03-21 | Sale | Chief Administrative Officer | 38,548 0.0085% | $0.46 | $17,894 | -15.56% | ||
| 2024-03-07 | Sale | Chief Administrative Officer | 38,548 0.0078% | $0.53 | $20,430 | -29.97% | ||
| 2024-02-22 | Sale | Chief Administrative Officer | 38,548 0.0123% | $0.61 | $23,325 | -34.83% | ||
| 2024-02-15 | Sale | Chief Administrative Officer | 38,548 0.0083% | $0.78 | $30,210 | -51.02% | ||
| 2024-01-25 | Sale | Chief Administrative Officer | 38,548 0.0078% | $0.73 | $27,997 | -45.31% | ||
| 2024-01-11 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.72 | $27,581 | -40.62% | ||
| 2023-12-28 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.93 | $35,904 | -52.56% | ||
| 2023-12-14 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.97 | $37,222 | -52.89% | ||
| 2023-11-30 | Sale | Chief Administrative Officer | 38,548 0.0082% | $0.88 | $33,753 | -46.31% | ||
| 2023-11-16 | Sale | Chief Administrative Officer | 38,548 0.0083% | $0.77 | $29,732 | -38.20% | ||
| 2023-11-02 | Sale | Chief Administrative Officer | 38,548 0.008% | $0.87 | $33,437 | -45.21% | ||
| 2023-10-19 | Sale | Chief Administrative Officer | 38,548 0.0081% | $0.81 | $31,397 | -39.22% | ||
| 2023-10-05 | Sale | Chief Administrative Officer | 38,548 0.0072% | $0.84 | $32,407 | -41.30% | ||
| 2023-09-21 | Sale | Chief Administrative Officer | 38,548 0.0081% | $1.00 | $38,583 | -47.52% | ||
| 2023-09-07 | Sale | Chief Administrative Officer | 40,894 0.0085% | $1.06 | $43,483 | -48.33% | ||
| 2023-09-05 | Sale | Head of Therapeutics Discovery | 2,538 0.0006% | $1.08 | $2,741 | -44.90% | ||
| 2023-08-24 | Sale | Chief Administrative Officer | 40,894 0.0078% | $1.05 | $43,119 | -41.48% |
Insider Historical Profitability
| HIBBS KATHY L | Chief Administrative Officer | 1252315 4.5815% | $3.61 | 0 | 24 | |
| Richards William G | Head of Therapeutics Discovery | 211041 0.7721% | $3.61 | 0 | 1 | |
| Hillan Kenneth J. | Chief Therapeutics Officer | 196083 0.7174% | $3.61 | 0 | 1 | |
| BROWN DOUGLAS R | director | 100000 0.3658% | $3.61 | 2 | 0 | |
| SCHELLER RICHARD H | director | 72388 0.2648% | $3.61 | 0 | 1 | |
| Lockhart James B. III | director | 50000 0.1829% | $3.61 | 1 | 0 | |
| Briggs Teresa | director | 25000 0.0915% | $3.61 | 1 | 0 | |
| Lovell Evan | 11467 0.042% | $3.61 | 2 | 0 | <0.0001% | |
| Bayliss Joshua | Chief Executive Officer | 50 0.0002% | $3.61 | 1 | 0 |
Institutional Investor Ownership
| BlackRock | $11.47M | 4.4 | 21.56M | -4.04% | -$483,356.61 | <0.0001 | |
| Newview Capital Partners I Llc | $10.31M | 3.97 | 19.46M | 0% | +$0 | 8.96 | |
| The Vanguard Group | $8.68M | 3.33 | 16.31M | -27.68% | -$3.32M | <0.0001 | |
| Euclidean Capital Llc | $5.45M | 2.09 | 10.24M | 0% | +$0 | 0.7 | |
| Geode Capital Management | $3.98M | 1.53 | 7.48M | +6.02% | +$225,979.46 | <0.0001 | |
| State Street | $3.4M | 1.31 | 6.4M | +11.5% | +$351,054.57 | <0.0001 | |
| Sapphire Ventures L L C | $2.82M | 1.08 | 5.29M | 0% | +$0 | 2.1 | |
| Renaissance Technologies | $2.58M | 0.99 | 4.85M | +39.39% | +$728,830.56 | <0.01 | |
| Northern Trust | $1.39M | 0.53 | 2.61M | -2.83% | -$40,511.25 | <0.0001 | |
| Wittenberg Investment Management Inc | $1.22M | 0.47 | 2.29M | +63.94% | +$475,369.77 | 0.43 | |
| Ensign Peak Advisors Inc | $1.17M | 0.45 | 2.2M | +3.65% | +$41,162.96 | <0.01 | |
| Charles Schwab | $1.17M | 0.45 | 2.2M | -9.73% | -$126,021.24 | <0.0001 | |
| Steel Partners Ltd | $1.11M | 0.43 | 2.1M | New | +$1.11M | 2.81 | |
| Millennium Management LLC | $886,429.00 | 0.34 | 1.67M | +1,598.14% | +$834,229.13 | <0.01 | |
| Nuveen | $747,931.00 | 0.29 | 1.41M | +44.85% | +$231,570.45 | <0.0001 | |
| Two Sigma | $726,489.00 | 0.28 | 1.37M | +56.64% | +$262,694.12 | <0.01 | |
| Invesco | $511,747.00 | 0.2 | 961,931 | +165.72% | +$319,161.51 | <0.0001 | |
| BNY Mellon | $469,107.00 | 0.18 | 881,779 | -10.18% | -$53,155.91 | <0.0001 | |
| Fidelity Investments | $393,132.00 | 0.15 | 738,971 | -26.71% | -$143,263.67 | <0.0001 | |
| Jane Street Capital | $376,366.00 | 0.14 | 707,455 | +66.27% | +$150,002.70 | <0.0001 | |
| Morgan Stanley | $361,072.00 | 0.14 | 678,707 | -25.82% | -$125,650.38 | <0.0001 | |
| Swiss National Bank | $287,759.00 | 0.11 | 540,900 | 0% | +$0 | <0.0001 | |
| Dragoneer Investment Group | $266,000.00 | 0.1 | 500,000 | 0% | +$0 | 0.01 | |
| UBS | $244,043.00 | 0.09 | 458,729 | +31.25% | +$58,103.25 | <0.0001 | |
| Susquehanna International Group | $232,160.00 | 0.09 | 436,390 | -26.89% | -$85,371.29 | <0.0001 | |
| RhumbLine Advisers | $222,292.00 | 0.09 | 417,859 | +5.44% | +$11,474.78 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $217,286.00 | 0.08 | 408,432 | -2.24% | -$4,972.61 | <0.0001 | |
| Citadel Advisors LLC | $205,545.00 | 0.08 | 386,363 | -77.51% | -$708,293.76 | <0.0001 | |
| Bank of America | $198,805.00 | 0.08 | 373,694 | +3.17% | +$6,113.21 | <0.0001 | |
| Goldman Sachs | $187,737.00 | 0.07 | 352,888 | -30.85% | -$83,753.02 | <0.0001 | |
| Ohio Strs | $185,000.00 | 0.07 | 349,600 | 0% | +$0 | <0.01 | |
| Mirador Capital Partners | $181,383.00 | 0.07 | 340,946 | +11.19% | +$18,258.74 | 0.04 | |
| AllianceBernstein | $178,906.00 | 0.07 | 336,290 | 0% | +$0 | <0.0001 | |
| CalSTRS | $150,624.00 | 0.06 | 283,128 | -3.67% | -$5,743.47 | <0.0001 | |
| Barclays | $146,000.00 | 0.06 | 274,332 | -42% | -$105,710.19 | <0.0001 | |
| Two Sigma Advisers LP | $141,086.00 | 0.05 | 265,200 | +337.62% | +$108,846.89 | <0.0001 | |
| TWO SIGMA SECURITIES LLC | $134,941.00 | 0.05 | 253,649 | +253.46% | +$96,763.69 | <0.01 | |
| Foresite Capital | $123,530.00 | 0.05 | 232,200 | 0% | +$0 | 0.13 | |
| Credit Suisse | $120,923.00 | 0.05 | 227,298 | 0% | +$0 | <0.0001 | |
| IEQ Capital | $121,125.00 | 0.05 | 227,679 | +0.06% | +$70.22 | <0.01 | |
| JPMorgan Chase | $102,497.00 | 0.04 | 192,664 | -26.23% | -$36,452.55 | <0.0001 | |
| AQR Capital | $96,161.00 | 0.04 | 180,754 | +1,076.25% | +$87,985.77 | <0.0001 | |
| Dimensional Fund Advisors | $92,624.00 | 0.04 | 174,105 | 0% | +$0 | <0.0001 | |
| Ubs Asset Management Americas Inc | $89,450.00 | 0.03 | 168,139 | 0% | +$0 | <0.0001 | |
| American International Group | $81,560.00 | 0.03 | 153,309 | +1.32% | +$1,064.53 | <0.0001 | |
| Gsa Capital Partners Llp | $80,000.00 | 0.03 | 150,944 | -22.27% | -$22,926.65 | 0.01 | |
| Legal & General | $78,328.00 | 0.03 | 147,233 | -33.11% | -$38,768.99 | <0.0001 | |
| Janus Henderson | $75,077.00 | 0.03 | 142,207 | -0.04% | -$31.68 | <0.0001 | |
| Deutsche Bank | $73,006.00 | 0.03 | 137,747 | +9.04% | +$6,054.73 | <0.0001 | |
| BKA Wealth Consulting, Inc. | $73,215.00 | 0.03 | 137,622 | 0% | +$0 | 0.13 |